Member access

4-Traders Homepage  >  Shares  >  Nyse  >  CVS Caremark Corporation    CVS   US1266501006

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

CVS Caremark 4th-Quarter Profit Rose 2.6% Amid Continued Sales Growth

02/06/2013 | 07:52am US/Eastern
Recommend:
0
   By Tess Stynes 
 

CVS Caremark Corp.'s (>> CVS Caremark Corporation) fourth-quarter earnings rose 2.6% as the company reported revenue growth in its pharmacy-services and retail drugstore operations.

For the year, the company raised its forecast for per-share adjusted earnings from continuing operations by two cents and now expects $3.86 to $4.

CVS's retail pharmacy business gained customers last year in the wake of a contract dispute between rival Walgreen Co.'s (>> Walgreen Company) and pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) that has since been resolved.

A wave of major generic drugs introductions is having a mixed effect on the industry. Though the copycat drugs carry higher margins than branded products, they command lower prices, hurting sales revenue.

CVS Caremark reported a profit of $1.13 billion, or 90 cents a share, up from $1.1 billion, or 81 cents a share, a year earlier. Excluding debt-extinguishment losses, acquisition-related charges and other items, adjusted earnings from continuing operations were $1.14. Revenue increased 11% to $31.39 billion.

Analysts polled by Thomson Reuters most recently projected earnings of $1.10 on revenue of $31.13 billion.

Revenue in the larger pharmacy-services business climbed 17% to $18.6 billion, reflecting new client starts, higher prices and growth of its Medicare Part D program. Pharmacy network claims processed rose 6.5%.

On the retail side, revenue increased 5.1% to $16.3 billion. Same-store sales were up 4% from a year earlier, as pharmacy same-store sales also improved by 4%. Same-store sales in the front end of the store grew 3.9%.

Shares closed Tuesday at $51.72 and were inactive premarket.

Write to Tess Stynes at tess.stynes@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Recommend :
0
React to this article
Latest news on CVS CAREMARK CORPORATION
2d ago CVS CAREMARK : pharmacy Consumer Survey Finds Three in Five Americans are Unawar..
2d ago CVS CAREMARK : pharmacy to Donate to Boys & Girls Clubs of America's Great Futur..
2d ago CVS CAREMARK : Accordant Health Services Receives NCQA Disease Management Accred..
4d ago CVS CAREMARK : pharmacy Consumer Survey Finds Three in Five Americans are Unawar..
4d ago CVS CAREMARK : pharmacy to Raise Funds in Support of Camp Wonder
5d ago CVS CAREMARK : pharmacy Consumer Survey Finds More than Half of Americans are Un..
6d ago CVS CAREMARK : pharmacy to Donate to Boys & Girls Clubs of America's Great Futur..
7d ago CVS CAREMARK : The Cetaphil® Brand Unveils New Limited-Edition Moisturizing Crea..
7d ago CVS CAREMARK : First MinuteClinic Walk-in Medical Clinics Open in Sacramento Are..
7d ago CVS CAREMARK : AIS Newsletter Examines Criticism of PBM Formulary Exclusion List..
Advertisement
Chart
Duration : Period :
CVS Caremark Corporation Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Income Statement Evolution
CVS Caremark Corporation : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF